Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Validation of Hemolytic Anemia Codes in the French Hospital Database

Julien Maquet, Hélène Derumeaux, MD PhD, Maryse Lapeyre-Mestre, MD PhD, Laurent Sailler, MD PhD, Guillaume Moulis, MD PhD

Blood (2019) 134 (Supplement_1): 3460.

https://doi.org/10.1182/blood-2019-124697

Published: 2019

Journal Articles

Serum Albumin Is an Independent Factor Predicting Survival in Patients with Peripheral T Cell Lymphoma: A Multi-Institutional Study from the Latin American Working Group for Lymphomas (GELL)

Henry Idrobo, MD, Brady E. Beltrán, MD, Luis Villela M, Marialejandra Torres Viera, MD, Victoria Otero, MD, Lorena Fiad, MD, Camila Peña, MD, Denisse A. Castro, MD, Yesenia M. Huerta- Collado, MD, Sally Rose Paredes, MD, Ivan Perdomo, MD, Pilar León, MD, Christine Rojas, MD, Virginia Abello, MD, Monica Osuna Pérez, MD, Juan Esteban Garcia-Robledo, MD, Luis E Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD

Blood (2019) 134 (Supplement_1): 4047.

https://doi.org/10.1182/blood-2019-123588

Published: 2019

Journal Articles

Risk Factors and Outcomes of Patients with Follicular Lymphoma Who Had Histologic Transformation at First Progression after First-Line Immunochemotherapy in the Gallium Study

Carla Casulo, Michael Herold, MD, Wolfgang Hiddemann, MD PhD, Sunil Iyengar, MD, Robert E. Marcus, FRCP, John F. Seymour, MBBS, PhD FRACP, Aino Launonen, MSc, Andrea Knapp, PhD, Tina G Nielsen, MD PhD, Farheen Mir, MBBS, MD

Blood (2019) 134 (Supplement_1): 5268.

https://doi.org/10.1182/blood-2019-123466

Published: 2019

Journal Articles

Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases

Rebecca Karp Leaf, MD, Christopher Ferreri, MD, Kerry Lynn Reynolds, MD, Deepa Rangachari, MD, James Mier, MD, Wesley Witteles, MD, George Ansstas, MD, Theodora Anagnostou, MD, Leyre Zubiri, MD, Zofia Piotrowska, MD, Thein H. Oo, MD, David Iberri, MD, Mark Yarchoan, MDPhD, April Salama, MD, Osama Rahma, David Leaf, MD

Blood (2018) 132 (Supplement 1): 1037.

https://doi.org/10.1182/blood-2018-99-111186

Published: 2018

Journal Articles

Evaluation of Tumor Burden for Predicting Survival in Patients with Follicular Lymphoma Receiving First-Line R-CHOP Treatment: Comparison of Different Definition of GELF Criteria

Harumi Kato, MD, Naoyuki Tange, MD, Chisako Iriyama, MD PhD, Yuki Kojima, MD, Hirofumi Taji, MD PhD, Tomohiro Kinoshita, MD PhD, Yasushi Yatabe, MD PhD, Shigeo Nakamura, MD PhD, Kazuhito Yamamoto, MDPhD

Blood (2017) 130 (Supplement 1): 4063.

https://doi.org/10.1182/blood.V130.Suppl_1.4063.4063

Published: 2017

Journal Articles

Risk of Central Nervous System Relapse in Patient with Peripheral T-Cell Lymphoma: Absolute Lymphocytes Count and Lymphocytes Percent at Diagnosis As Predictors

Tariq Zuheir Kewan, MD, Mahmoud Husni Hajyousef, MD, Associate Professor, Deeb Jamil Zahran, MD, Sohaib Mahmoud Al-Khatib, MD

Blood (2017) 130 (Supplement 1): 5185.

https://doi.org/10.1182/blood.V130.Suppl_1.5185.5185

Published: 2017

Journal Articles

Conditioning Chemotherapy with BOR-MEL in Autologous Stem Cell Transplant in Multiple Myeloma

Jose L Alvarez, Sr., MD, M. Augusta Pacheco, MD, Pedro Guzman, MD, Leire Montoya, MD, Veronica MENA, MD, Maricela Ortiz, MD, Rosa Jimenez, MD, Martha Alvarado, MD

Blood (2017) 130 (Supplement 1): 5531.

https://doi.org/10.1182/blood.V130.Suppl_1.5531.5531

Published: 2017

Journal Articles

Retrospective Analysis of NK/T Cell Lymphoma Prognostic Index (NKPI), EBV-DNA and Soluble IL-2 Receptor (sIL2R) for Extranodal NK/T-Cell Lymphoma, Nasal Type

Norihito Inoue, MD, Noriko Nishimura, MD PhD, Anna Takahashi, MD, Hirofumi Yamauchi, MD, Yoshiharu Kusano, MD, Kyoko Ueda, MD, Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Yasuhito Terui, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2016) 128 (22): 5360.

https://doi.org/10.1182/blood.V128.22.5360.5360

Published: 2016

Journal Articles

Double Hit Lymphomas: Role of Immunohistochemistry in the Era of Florescent in-Situ Hybridization

Vineela Kasireddy, MD

Blood (2016) 128 (22): 5405.

https://doi.org/10.1182/blood.V128.22.5405.5405

Published: 2016

Journal Articles

The Risk of Central Nervous System (CNS) Relapses in Patients with Peripheral T-Cell Lymphoma

Dai Chihara, MD PhD, Michelle A Fanale, MD, Roberto N. Miranda, MD, Mansoor Noorani, Jason R. Westin, MD, Loretta J. Nastoupil, MD, Fredrick B. Hagemeister, MD, Luis E. Fayad, MD, Jorge E. Romaguera, MD, Felipe Samaniego, MD, Francesco Turturro, MD, Hun Ju Lee, MD, Sattva S. Neelapu, MD, Alma Rodriguez, MD, Michael Wang, MD, Nathan Fowler, MD, L. Jeffrey Medeiros, MD, Richard Eric Davis, MD, Yasuhiro Oki, MD

Blood (2016) 128 (22): 4153.

https://doi.org/10.1182/blood.V128.22.4153.4153

Published: 2016

Journal Articles

Methotrexate-Cytarabine-Dexamethasone Combination Chemotherapy with or without Rituximab in Patients with Primary Central Nervous System Lymphoma

Jing Liu, Xuefei Sun, Xueyan Bai, Yuedan Chen, Jun Qian, Hong Zhu, Yaming Wang, Nan Ji, Shengjun Sun, Yajie Wang, Yuanbo Liu

Blood (2016) 128 (22): 4218.

https://doi.org/10.1182/blood.V128.22.4218.4218

Published: 2016

Journal Articles

Evaluation of the Revised International Staging System (R-ISS) in an Independent Cohort of Unselected Patients with Multiple Myeloma

Efstathios Kastritis, MD, Evangelos Terpos, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Dimitrios Ziogas, Ioannis Panagiotidis, Despoina Fotiou, Dimitra Gika, Despoina Kalapanida, Eftychia Kafantari, Maria Roussou, Flora Zagouri, Stavroula Giannouli, Athanasios Zomas, Kostas Konstantopoulos, Meletios A. Dimopoulos

Blood (2015) 126 (23): 3045.

https://doi.org/10.1182/blood.V126.23.3045.3045

Published: 2015

Journal Articles

A New Prognostic Model for Multiple Myeloma Patients in the Era of Novel Agents

Hyungwoo Cho, MD, Dok Hyun Yoon, MD PhD, Kihyun Kim, Sung-Soo Yoon, Chang-Ki Min, MD, PhD, HyeonSeok Eom, MD, PhD, Jin Seok Kim, Je-Jung Lee, Jae Hoon Lee, Cheolwon Suh

Blood (2015) 126 (23): 4185.

https://doi.org/10.1182/blood.V126.23.4185.4185

Published: 2015

Journal Articles

Gene Expression Profiling of Extramedullary Disease-Related Toward Identification of a Terminal Disease Pathway in Multiple Myeloma

Sarah Waheed, MD, Hongwei Wang, Pingping Qu, PhD, Christoph Heuck, MD, Aasiya Matin, Yogesh Jethava, MB, MRCP, MD FRCPath, Frits van Rhee, MD PhD, Antje Hoering, Bart Barlogie, MD PhD, Faith E Davies, MD, Gareth J Morgan, MDPhD

Blood (2015) 126 (23): 1777.

https://doi.org/10.1182/blood.V126.23.1777.1777

Published: 2015

Journal Articles

R-CHOEP-14 Is Associated with Superior Overall Survival Compared to R-CHOP-21 and R-CHOP-14 in Patients with DLBCL ≤70 Years – a Swedish Lymphoma Registry Population Based Study

Tove Wästerlid, MD PhDstudent, Erzsebet Szekely, MD PhDstudent, Linda Werner Hartman, Mats Jerkeman, MD PhD

Blood (2014) 124 (21): 4427.

https://doi.org/10.1182/blood.V124.21.4427.4427

Published: 2014

Journal Articles

Clinical Outcomes and Prognostic Factors of Front-Line Autologous Stem Cell Transplantation in Patients with Extranodal NK/T-Cell Lymphoma

Ho-Young Yhim, MD PhD, Jin Seok Kim, Yeung-Chul Mun, Chu-Myong Seong, Joon Ho Moon, Yong Park, MD PhD, Jae-Cheol Jo, MD, Seok Jin Kim, MD PhD, Jae-Yong Kwak, MD PhD, Je-Jung Lee, MD PhD, Deok-Hwan Yang, MD PhD

Blood (2014) 124 (21): 2523.

https://doi.org/10.1182/blood.V124.21.2523.2523

Published: 2014

Journal Articles

Prognostic Impact of Gender in Diffuse Large B Cell Lymphoma Patients Treated with R-CHOP Therapy

Blood (2014) 124 (21): 5391.

https://doi.org/10.1182/blood.V124.21.5391.5391

Published: 2014

Journal Articles

Upfront Autologous Stem Cell Transplantation Overcome the poor Prognosis of Non-Germinal Center Subtype of diffuse Large B-Cell Lymphoma in Patients with Advanced Stage and Elevated Serum Lactate Dehydrogenase

Yu Ri Kim, MD PhD, Soo-Jeong Kim, MD, June-Won Cheong, MD, PhD, Yundeok Kim, MD, Ji Eun Jang, MD, Jung Yeon Lee, MD, Deok-Hwan Yang, Hyewon Lee, MD, Hyeon-Seok Eom, Yoo Hong Min, MD,PhD, Jin Seok Kim

Blood (2014) 124 (21): 3998.

https://doi.org/10.1182/blood.V124.21.3998.3998

Published: 2014

Journal Articles

Prognostic Impact Of Gender In Diffuse Large B Cell Lymphoma Patients Treated With R-CHOP Therapy

Hiroyuki Takahashi, MD, Naoto Tomita, MD, Rika Kawasaki, MD, Chizuko Hashimoto, MD, Etsuko Yamazaki, MD, Jun Taguchi, MD, Rika Sakai, MD, Shin Fujisawa, MD, Koji Ogawa, MD, Yoshiaki Ishigatsubo, MD

Blood (2013) 122 (21): 5079.

https://doi.org/10.1182/blood.V122.21.5079.5079

Published: 2013

Journal Articles

MIB-1 Labeling Index As a Prognostic Factor in Patients with Follicular Lymphoma Treated with R-CHOP Therapy

Eri Yamamoto, MD, Naoto Tomita, MD, Seiji Sakata, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MD, Yuki Nakajima, MD, Kazuho Miyashita, MD, Takayoshi Tachibana, MD, Hirotaka Takasaki, MD, Masatsugu Tanaka, MD, Chizuko Hashimoto, MD, Hideyuki Koharazawa, MD, Katsumichi Fujimaki, MD, Jun Taguchi, MD, Hiroshi Harano, MD, Shigeki Motomura, MD, Yoshiaki Ishigatsubo, MD

Blood (2012) 120 (21): 1561.

https://doi.org/10.1182/blood.V120.21.1561.1561

Published: 2012

NARROW

Validation of Hemolytic Anemia Codes in the French Hospital Database

Serum Albumin Is an Independent Factor Predicting Survival in Patients with Peripheral T Cell Lymphoma: A Multi-Institutional Study from the Latin American Working Group for Lymphomas (GELL)

Risk Factors and Outcomes of Patients with Follicular Lymphoma Who Had Histologic Transformation at First Progression after First-Line Immunochemotherapy in the Gallium Study

Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases

Evaluation of Tumor Burden for Predicting Survival in Patients with Follicular Lymphoma Receiving First-Line R-CHOP Treatment: Comparison of Different Definition of GELF Criteria

Risk of Central Nervous System Relapse in Patient with Peripheral T-Cell Lymphoma: Absolute Lymphocytes Count and Lymphocytes Percent at Diagnosis As Predictors

Conditioning Chemotherapy with BOR-MEL in Autologous Stem Cell Transplant in Multiple Myeloma

Retrospective Analysis of NK/T Cell Lymphoma Prognostic Index (NKPI), EBV-DNA and Soluble IL-2 Receptor (sIL2R) for Extranodal NK/T-Cell Lymphoma, Nasal Type

Double Hit Lymphomas: Role of Immunohistochemistry in the Era of Florescent in-Situ Hybridization

The Risk of Central Nervous System (CNS) Relapses in Patients with Peripheral T-Cell Lymphoma

Methotrexate-Cytarabine-Dexamethasone Combination Chemotherapy with or without Rituximab in Patients with Primary Central Nervous System Lymphoma

Evaluation of the Revised International Staging System (R-ISS) in an Independent Cohort of Unselected Patients with Multiple Myeloma

A New Prognostic Model for Multiple Myeloma Patients in the Era of Novel Agents

Gene Expression Profiling of Extramedullary Disease-Related Toward Identification of a Terminal Disease Pathway in Multiple Myeloma

R-CHOEP-14 Is Associated with Superior Overall Survival Compared to R-CHOP-21 and R-CHOP-14 in Patients with DLBCL ≤70 Years – a Swedish Lymphoma Registry Population Based Study

Clinical Outcomes and Prognostic Factors of Front-Line Autologous Stem Cell Transplantation in Patients with Extranodal NK/T-Cell Lymphoma

Prognostic Impact of Gender in Diffuse Large B Cell Lymphoma Patients Treated with R-CHOP Therapy

Upfront Autologous Stem Cell Transplantation Overcome the poor Prognosis of Non-Germinal Center Subtype of diffuse Large B-Cell Lymphoma in Patients with Advanced Stage and Elevated Serum Lactate Dehydrogenase

Prognostic Impact Of Gender In Diffuse Large B Cell Lymphoma Patients Treated With R-CHOP Therapy

MIB-1 Labeling Index As a Prognostic Factor in Patients with Follicular Lymphoma Treated with R-CHOP Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only